146 related articles for article (PubMed ID: 28883851)
1. Improvement of exercise tolerance in cardiopulmonary testing with sustained safety after regular training in outpatients with systolic heart failure (NYHA III) and an implantable cardioverter-defibrillator. Prospective 18-month randomized study.
Smolis-Bąk E; Rymuza H; Kazimierska B; Kowalik I; Chwyczko T; Borowiec A; Rongies W; Jankowska A; Szwed H; Dąbrowski R
Arch Med Sci; 2017 Aug; 13(5):1094-1101. PubMed ID: 28883851
[TBL] [Abstract][Full Text] [Related]
2. Hospital-based and telemonitoring guided home-based training programs: effects on exercise tolerance and quality of life in patients with heart failure (NYHA class III) and cardiac resynchronization therapy. A randomized, prospective observation.
Smolis-Bąk E; Dąbrowski R; Piotrowicz E; Chwyczko T; Dobraszkiewicz-Wasilewska B; Kowalik I; Kazimierska B; Jędrzejczyk B; Smolis R; Gepner K; Maciąg A; Sterliński M; Szwed H
Int J Cardiol; 2015 Nov; 199():442-7. PubMed ID: 26276068
[TBL] [Abstract][Full Text] [Related]
3. Exercise training program in patients with NYHA III class systolic heart failure - Parallel comparison to the effects of resynchronization therapy.
Smolis-Bąk E; Chwyczko T; Kowalik I; Borowiec A; Maciąg A; Szwed H; Dąbrowski R
Adv Med Sci; 2019 Sep; 64(2):241-245. PubMed ID: 30822631
[TBL] [Abstract][Full Text] [Related]
4. Combined cardiac resynchronization and implantable cardioversion defibrillation in advanced chronic heart failure: the MIRACLE ICD Trial.
Young JB; Abraham WT; Smith AL; Leon AR; Lieberman R; Wilkoff B; Canby RC; Schroeder JS; Liem LB; Hall S; Wheelan K;
JAMA; 2003 May; 289(20):2685-94. PubMed ID: 12771115
[TBL] [Abstract][Full Text] [Related]
5. Effects of cardiac resynchronization on disease progression in patients with left ventricular systolic dysfunction, an indication for an implantable cardioverter-defibrillator, and mildly symptomatic chronic heart failure.
Abraham WT; Young JB; León AR; Adler S; Bank AJ; Hall SA; Lieberman R; Liem LB; O'Connell JB; Schroeder JS; Wheelan KR;
Circulation; 2004 Nov; 110(18):2864-8. PubMed ID: 15505095
[TBL] [Abstract][Full Text] [Related]
6. Impact of cardiac resynchronization therapy on exercise performance, functional capacity, and quality of life in systolic heart failure with QRS prolongation: COMPANION trial sub-study.
De Marco T; Wolfel E; Feldman AM; Lowes B; Higginbotham MB; Ghali JK; Wagoner L; Kirlin PC; Kennett JD; Goel S; Saxon LA; Boehmer JP; Mann D; Galle E; Ecklund F; Yong P; Bristow MR
J Card Fail; 2008 Feb; 14(1):9-18. PubMed ID: 18226768
[TBL] [Abstract][Full Text] [Related]
7. Home-based telemonitored Nordic walking training is well accepted, safe, effective and has high adherence among heart failure patients, including those with cardiovascular implantable electronic devices: a randomised controlled study.
Piotrowicz E; Zieliński T; Bodalski R; Rywik T; Dobraszkiewicz-Wasilewska B; Sobieszczańska-Małek M; Stepnowska M; Przybylski A; Browarek A; Szumowski Ł; Piotrowski W; Piotrowicz R
Eur J Prev Cardiol; 2015 Nov; 22(11):1368-77. PubMed ID: 25261268
[TBL] [Abstract][Full Text] [Related]
8. Moderate exercise training improves functional capacity, quality of life, and endothelium-dependent vasodilation in chronic heart failure patients with implantable cardioverter defibrillators and cardiac resynchronization therapy.
Belardinelli R; Capestro F; Misiani A; Scipione P; Georgiou D
Eur J Cardiovasc Prev Rehabil; 2006 Oct; 13(5):818-25. PubMed ID: 17001224
[TBL] [Abstract][Full Text] [Related]
9. Effects of renal denervation therapy on cardiac function and malignant arrhythmia in patients with reduced left ventricular ejection fraction and narrow QRS complexes treated with implantable cardioverter defibrillator.
Yang W; Xu YL; Gao JQ; Shen D; Li M; Fa JJ; Zhang Y; Wang R; Hou SX; Hu WY; Jin HG; Liu ZJ
Front Physiol; 2022; 13():938486. PubMed ID: 36035484
[No Abstract] [Full Text] [Related]
10. Aerobic interval training in patients with heart failure and an implantable cardioverter defibrillator: a controlled study evaluating feasibility and effect.
Isaksen K; Munk PS; Valborgland T; Larsen AI
Eur J Prev Cardiol; 2015 Mar; 22(3):296-303. PubMed ID: 24403295
[TBL] [Abstract][Full Text] [Related]
11. Efficacy and safety of early comprehensive cardiac rehabilitation following the implantation of cardioverter-defibrillator.
Śmiałek J; Lelakowski J; Majewski J
Kardiol Pol; 2013; 71(10):1021-8. PubMed ID: 24197582
[TBL] [Abstract][Full Text] [Related]
12. [Cardiopulmonary exercise test and heart rate variability in patients with congestive heart failure who underwent physical rehabilitation].
Kubinyi A; Bacior B; Szot W; Klecha A; Kawecka-Jaszcz K
Przegl Lek; 2003; 60(11):732-6. PubMed ID: 15058045
[TBL] [Abstract][Full Text] [Related]
13. Initial experience with an implantable cardioverter-defibrillator incorporating cardiac resynchronization therapy.
Kühlkamp V;
J Am Coll Cardiol; 2002 Mar; 39(5):790-7. PubMed ID: 11869843
[TBL] [Abstract][Full Text] [Related]
14. Cardiac resynchronization therapy for the treatment of heart failure in patients with intraventricular conduction delay and malignant ventricular tachyarrhythmias.
Higgins SL; Hummel JD; Niazi IK; Giudici MC; Worley SJ; Saxon LA; Boehmer JP; Higginbotham MB; De Marco T; Foster E; Yong PG
J Am Coll Cardiol; 2003 Oct; 42(8):1454-9. PubMed ID: 14563591
[TBL] [Abstract][Full Text] [Related]
15. Exercise performance and training in patients with implantable cardioverter-defibrillators and coronary heart disease.
Vanhees L; Schepers D; Heidbüchel H; Defoor J; Fagard R
Am J Cardiol; 2001 Mar; 87(6):712-5. PubMed ID: 11249888
[TBL] [Abstract][Full Text] [Related]
16. Cardiac-resynchronization therapy in patients with systolic heart failure and QRS interval ≤130 ms: insights from a meta-analysis.
Shah RM; Patel D; Molnar J; Ellenbogen KA; Koneru JN
Europace; 2015 Feb; 17(2):267-73. PubMed ID: 25164431
[TBL] [Abstract][Full Text] [Related]
17. Association of Implantable Cardioverter Defibrillators With Survival in Patients With and Without Improved Ejection Fraction: Secondary Analysis of the Sudden Cardiac Death in Heart Failure Trial.
Adabag S; Patton KK; Buxton AE; Rector TS; Ensrud KE; Vakil K; Levy WC; Poole JE
JAMA Cardiol; 2017 Jul; 2(7):767-774. PubMed ID: 28724134
[TBL] [Abstract][Full Text] [Related]
18. Impact of Improved Left Ventricular Systolic Function on the Recurrence of Ventricular Arrhythmia in Heart Failure Patients With an Implantable Cardioverter-Defibrillator.
Kim M; Kim J; Lee JH; Hwang YM; Kim MS; Nam GB; Choi KJ; Kim JJ; Kim YH
J Cardiovasc Electrophysiol; 2016 Oct; 27(10):1191-1198. PubMed ID: 27334231
[TBL] [Abstract][Full Text] [Related]
19. Haemodynamic effects of etomidate, propofol and electrical shock in patients undergoing implantable cardioverter-defibrillator testing.
Zgoła K; Kułakowski P; Czepiel A; Świątkowski M; Makowska E; Błachnio E; Soszyńska M; Misiewicz M
Kardiol Pol; 2014; 72(8):707-15. PubMed ID: 24846355
[TBL] [Abstract][Full Text] [Related]
20. Impact of lifestyle modification on left ventricular function and cardiopulmonary exercise capacity in patients with heart failure with normal ejection fraction and cardiometabolic syndrome: a prospective interventional study.
Ritzel A; Otto F; Bell M; Sabin G; Wieneke H
Acta Cardiol; 2015 Feb; 70(1):43-50. PubMed ID: 26137802
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
